A network aimed at understanding and treating cancer cachexia
The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer Cachexia
This study is looking into cancer cachexia, a tough condition that causes weight loss and muscle loss in many cancer patients, to find out how tumors affect the body and to discover new ways to help improve treatment and quality of life for those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11163814 on NIH RePORTER |
What this research studies
This research focuses on cancer cachexia, a severe condition affecting around 80% of cancer patients, characterized by significant weight loss and muscle wasting. The project brings together a diverse team of scientists and clinicians to explore the underlying mechanisms of cachexia, including how tumors influence metabolic processes and appetite. By utilizing advanced methodologies and collaborative efforts, the research aims to identify potential therapeutic targets and improve patient outcomes. Patients may benefit from new insights into treatment options that could enhance their quality of life and survival rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients experiencing significant weight loss and muscle wasting due to cachexia.
Not a fit: Patients who do not have cancer or those not experiencing cachexia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective therapies for cancer cachexia, improving treatment responses and quality of life for patients.
How similar studies have performed: While there has been extensive research on cancer cachexia, this multidisciplinary approach is novel and aims to uncover new therapeutic avenues.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Goncalves, Marcus Dasilva — New York University School of Medicine
- Study coordinator: Goncalves, Marcus Dasilva
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.